chloramphenicol has been researched along with warfarin in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (52.08) | 18.7374 |
1990's | 3 (6.25) | 18.2507 |
2000's | 11 (22.92) | 29.6817 |
2010's | 9 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gubernator, K; Kansy, M; Senner, F | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Botta, M; Dreassi, E; Falchi, F; Maga, G; Santucci, A; Schenone, S; Zizzari, AT | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Conradi, R; Lee, PH; Shanmugasundaram, V | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Avdeef, A; Tam, KY | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Clarke, CH; Shankel, DM | 1 |
Ackermann, E | 1 |
Berger, W | 1 |
Hahlbrock, K; Ragg, H | 1 |
Lovering, EG; McGilveray, IJ; McMillan, I; Tostowaryk, W | 1 |
Ebringer, L; Krajcovic, J; Polónyi, J | 1 |
Datta, P; Sumantran, VN; Tranguch, AJ | 1 |
Maier, RJ; Novak, PD | 1 |
Balfour, C; Halpert, J; Kaminsky, LS | 1 |
Balfour, C; Dunbar, D; Halpert, J; Kaminsky, LS; Miller, NE; Morgan, ET | 1 |
Sellers, E; Weser, JK | 1 |
Eipe, J | 1 |
Fossati, C | 1 |
Vorherr, H | 1 |
Seiler, K | 1 |
Nambudiri, AM; Towers, GH; Tregunna, EB; Vance, CP | 1 |
Berger, W; Spring, P | 1 |
Bosmann, HB | 1 |
Bernacki, RJ; Bosmann, HB | 1 |
Lai, CM; Levy, G; Yacobi, A | 1 |
Betnér, I; Halpert, J; Näslund, B | 1 |
Ekins, S; Ring, BJ; VandenBranden, M; Wrighton, SA | 1 |
Conforti, A; Ghiotto, E; Leone, R; Velo, G | 1 |
BITZER, W; CHILDRESS, RC | 1 |
AMSTUTZ, P; BAROIS, A; GORCE, F; GOULON, M; RAPIN, M | 1 |
BURNS, JJ; CONNEY, AH | 1 |
Atichartpongkul, S; Fuangthong, M; Mongkolsuk, S; Rangkadilok, N; Sallabhan, R; Satayavivad, J; Sriprang, R | 1 |
Geng, RX; Ji, QG; Shi, Y; Zhou, CH; Zhou, XD | 1 |
7 review(s) available for chloramphenicol and warfarin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antimutagenesis in microbial systems.
Topics: Acridines; Antipsychotic Agents; Bacteria; Caffeine; Chloramphenicol; Dactinomycin; Dibenzocycloheptenes; DNA Repair; Escherichia coli; Fungi; Genes; Histidine; Manganese; Mutagens; Mutation; Phenothiazines; Polyamines; Purine Nucleosides; Quinacrine; Radiation Effects; Rosaniline Dyes; Ultraviolet Rays; Uracil; Warfarin | 1975 |
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
Drugs affecting therapy with anticoagulants.
Topics: Anticoagulants; Chloramphenicol; Clofibrate; Contraceptives, Oral; Coumarins; Diuretics; Drug Interactions; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethanol; Heparin; Humans; Hypnotics and Sedatives; Phenylbutazone; Phenytoin; Salicylates; Thyroxine; Tolbutamide; Vitamin K | 1972 |
[Liver damage due to drugs. I].
Topics: Arsenicals; Chemical and Drug Induced Liver Injury; Chloramphenicol; Cholestasis; Coumarins; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Halothane; Humans; Imipramine; Liver; Methotrexate; Methyldopa; Nicotinic Acids; Oxacillin; Phenylbutazone; Testosterone; Tetracycline | 1974 |
Drug excretion in breast milk.
Topics: Anti-Bacterial Agents; Barbiturates; Biological Transport, Active; Breast; Breast Feeding; Caffeine; Chloramphenicol; Contraceptives, Oral; Coumarins; Female; Fluorine; Humans; Hydrogen-Ion Concentration; Infant; Infant, Newborn; Infant, Premature, Diseases; Jaundice, Neonatal; Lactation; Meprobamate; Milk, Human; Models, Biological; Morphine; Nicotine; Pesticides; Pharmaceutical Preparations; Phenytoin; Potassium Iodide; Pregnancy; Salicylates; Sulfonamides; Time Factors | 1974 |
THERAPEUTIC IMPLICATIONS OF DRUG METABOLISM.
Topics: Aminopyrine; Chloramphenicol; Coumarins; Dicumarol; Humans; Metabolism; Pharmaceutical Preparations; Pharmacology; Phenacetin; Phenobarbital; Phenylbutazone | 1964 |
41 other study(ies) available for chloramphenicol and warfarin
Article | Year |
---|---|
Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes.
Topics: Absorption; Adsorption; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Membranes, Artificial; Permeability; Pharmacokinetics; Spectrophotometry, Ultraviolet | 1998 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Determination of permeability and lipophilicity of pyrazolo-pyrimidine tyrosine kinase inhibitors and correlation with biological data.
Topics: Humans; Lipids; Membranes, Artificial; Permeability; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-abl; Pyrazoles; Pyrimidines | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay.
Topics: 1-Methyl-3-isobutylxanthine; Cell Line; Cell Membrane Permeability; Humans; Models, Biological; Quantitative Structure-Activity Relationship; Skin Absorption | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Pharmacokinetics in liver cirrhosis].
Topics: Aminopyrine; Biotransformation; Chloramphenicol; Coumarins; Half-Life; Humans; Kinetics; Liver Cirrhosis; Pharmaceutical Preparations; Phenylbutazone; Salicylates; Tolbutamide | 1977 |
[Interactions between oral antidiabetics and other drugs].
Topics: Chloramphenicol; Coumarins; Drug Interactions; Humans; Hypoglycemic Agents; Probenecid; Sulfonamides | 1976 |
Light-induced changes of enzyme activities in parsley cell suspension cultures. Effects of inhibitors of RNA and protein synthesis.
Topics: Ammonia-Lyases; Cells, Cultured; Chloramphenicol; Coenzyme A Ligases; Coumarins; Cycloheximide; Dactinomycin; Flavonoids; Isomerases; Light; Phenylalanine; Plant Proteins; Plants; Protein Biosynthesis; Puromycin; RNA; Time Factors; Transcription, Genetic | 1975 |
Comparative bioavailabilities from truncated blood level curves.
Topics: Acetaminophen; Aminosalicylic Acids; Biological Availability; Biopharmaceutics; Chloramphenicol; Chlordiazepoxide; Digoxin; Humans; Isoniazid; Kinetics; Pharmaceutical Preparations; Phenylbutazone; Sulfamethizole; Tetracycline; Time Factors; Warfarin | 1975 |
Quinolones and coumarins eliminate chloroplasts from Euglena gracilis.
Topics: 4-Quinolones; Animals; Anti-Infective Agents; Chloramphenicol; Chloroplasts; Coumarins; Darkness; Euglena gracilis; Hydrogen-Ion Concentration; Microscopy, Electron; Rifampin; Temperature; Topoisomerase II Inhibitors | 1989 |
Increased expression of biodegradative threonine dehydratase of Escherichia coli by DNA gyrase inhibitors.
Topics: Aminocoumarins; Blotting, Western; Chloramphenicol; Coumarins; DNA Topoisomerases, Type II; DNA, Superhelical; Enzyme Induction; Escherichia coli; Mutation; Nalidixic Acid; Rifampin; Temperature; Threonine Dehydratase; Topoisomerase II Inhibitors | 1989 |
Inhibition of hydrogenase synthesis by DNA gyrase inhibitors in Bradyrhizobium japonicum.
Topics: Aminocoumarins; Bacterial Proteins; Chloramphenicol; Coumarins; Gene Expression Regulation; Hydrogenase; Nalidixic Acid; Novobiocin; Rhizobiaceae; Rifampin; Topoisomerase II Inhibitors | 1987 |
Effect of chloramphenicol administration in vivo on cytochrome P-450-dependent monooxygenase activities in liver microsomes from uninduced male rats.
Topics: Androstenedione; Animals; Chloramphenicol; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Microsomes, Liver; Oxygenases; Progesterone; Rats; Rats, Inbred Strains; Warfarin | 1988 |
Isozyme selectivity of the inhibition of rat liver cytochromes P-450 by chloramphenicol in vivo.
Topics: Animals; Benzoflavones; beta-Naphthoflavone; Chloramphenicol; Clofibrate; Cytochrome P-450 Enzyme Inhibitors; Isoenzymes; Lauric Acids; Liver; Male; Mixed Function Oxygenases; Phenobarbital; Pregnenolone Carbonitrile; Rats; Rats, Inbred Strains; Safrole; Steroid 16-alpha-Hydroxylase; Substrate Specificity; Testosterone; Warfarin | 1985 |
[Defect in oral anticoagulation. Etiology and explanation].
Topics: Anticoagulants; Blood Coagulation Disorders; Chloramphenicol; Coumarins; Drug Interactions; Glucagon; Humans; Models, Biological; Neomycin; Phenylbutazone; Protein Binding; Quinidine; Vitamin K | 1972 |
Styrylpyrone biosynthesis in Polyporus hispidus. I. Action spectrum and photoregulation of pigment and enzyme formation.
Topics: Ammonia-Lyases; Basidiomycota; Carbon Radioisotopes; Cell-Free System; Chloramphenicol; Cinnamates; Coumarins; Cycloheximide; Darkness; Light; Lighting; Mixed Function Oxygenases; Phenylalanine; Photochemistry; Pigments, Biological; Pyrans; Styrenes; Time Factors | 1974 |
[Affecting the blood sugar lowering action of oral antidiabetics by other drugs and renal insufficiency].
Topics: Blood Glucose; Carbohydrate Metabolism; Chloramphenicol; Contraceptives, Oral; Coumarins; Diabetes Complications; Diabetic Nephropathies; Drug Synergism; Female; Glucose Tolerance Test; Humans; Hypoglycemia; Hypoglycemic Agents; Phenylbutazone; Pyrimidines; Sulfonic Acids | 1970 |
Macromolecular synthesis: effects of vitamin K and warfarin on macromolecular synthesis in Escherichia coli.
Topics: Bacterial Proteins; Carbon Isotopes; Chloramphenicol; Cycloheximide; DNA, Bacterial; Escherichia coli; Glucosamine; Leucine; Macromolecular Substances; RNA, Bacterial; Thymidine; Tritium; Uridine; Vitamin K; Warfarin | 1971 |
Non-equivalent preparations of the same drug.
Topics: Chloramphenicol; Dosage Forms; Humans; Nitrofurantoin; Oxytetracycline; Pharmaceutical Preparations; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Tetracycline; Therapeutic Equivalency; Tolbutamide; Warfarin | 1971 |
Warfarin and vitamin K accelerate protein and glycoprotein synthesis in isolated rat liver mitochondria in vitro.
Topics: Animals; Brain; Carbon Isotopes; Cell Fractionation; Chloramphenicol; Culture Techniques; Cycloheximide; Depression, Chemical; DNA; Fucose; Glycoproteins; Leucine; Leukemia, Experimental; Liver; Mice; Microsomes, Liver; Mitochondria; Mitochondria, Liver; Nucleoside Diphosphate Sugars; Protein Biosynthesis; Rats; RNA; Stimulation, Chemical; Thymidine; Tritium; Uridine; Vitamin K 1; Warfarin | 1970 |
Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
Topics: Animals; Blood Proteins; Chloramphenicol; Drug Interactions; In Vitro Techniques; Kinetics; Male; Protein Binding; Prothrombin; Rats; Rats, Inbred Strains; Stereoisomerism; Warfarin | 1984 |
Suicide inactivation of rat liver cytochrome P-450 by chloramphenicol in vivo and in vitro.
Topics: 7-Alkoxycoumarin O-Dealkylase; Animals; Benzene Derivatives; Chloramphenicol; Coumarins; Cytochrome P-450 Enzyme Inhibitors; Iodobenzoates; Male; Microsomes, Liver; NADH, NADPH Oxidoreductases; NADPH Oxidases; Oxygenases; Phenobarbital; Rats; Rats, Inbred Strains | 1983 |
Examination of purported probes of human CYP2B6.
Topics: Aryl Hydrocarbon Hydroxylases; B-Lymphocytes; Benzoflavones; Blotting, Western; Cell Line; Chloramphenicol; Chromatography, High Pressure Liquid; Coumarins; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ditiocarb; Humans; In Vitro Techniques; Kinetics; Microsomes; Microsomes, Liver; Molecular Probes; Orphenadrine; Oxidoreductases, N-Demethylating; Substrate Specificity | 1997 |
Potential interaction between warfarin and ocular chloramphenicol.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; Chloramphenicol; Drug Interactions; Female; Humans; International Normalized Ratio; Warfarin | 1999 |
CAVERNOUS SINUS THROMBOSIS: REPORT OF CASE.
Topics: Cavernous Sinus; Cavernous Sinus Thrombosis; Chloramphenicol; Heparin; Humans; Intracranial Embolism; Intracranial Embolism and Thrombosis; Penicillins; Streptomycin; Thrombosis; Warfarin | 1964 |
[ANURIA CAUSED BY ACUTE INTERSTITIAL NEPHROPATHY IN THE COURSE OF PROLONGED PHENINDIONE TREATMENT].
Topics: Anuria; Chloramphenicol; Coma; Coumarins; Dermatitis; Diagnosis; Dialysis; Eosinophils; Erythromycin; Fever; Isoniazid; Methicillin; Nephritis; Nephritis, Interstitial; Pathology; Penicillins; Peritoneal Cavity; Phenindione; Renal Dialysis; Streptomycin; Toxicology | 1964 |
The omlA gene is involved in multidrug resistance and its expression is inhibited by coumarins in Xanthomonas campestris pv. phaseoli.
Topics: Aminocoumarins; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Base Sequence; Chloramphenicol; Coumarins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression; Lipoproteins; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Insertional; Novobiocin; Promoter Regions, Genetic; Sodium Dodecyl Sulfate; Transcription Initiation Site; Transcription, Genetic; Vitamin K 3; Xanthomonas campestris | 2008 |
[Synthesis and antimicrobial evaluation of coumarin-based benzotriazoles and their synergistic effects with chloromycin and fluconazole].
Topics: Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Chloramphenicol; Coumarins; Drug Synergism; Fluconazole; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Triazoles | 2011 |